{
    "2019-12-30": [
        [
            {
                "time": "2023-10-16",
                "original_text": "US Indexes Close Lower Monday",
                "features": {
                    "keywords": [
                        "US",
                        "Indexes",
                        "Close",
                        "Lower",
                        "Monday"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "general_market"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-16",
                "original_text": "Urbem's 'Wonderful Business' Series: Waters",
                "features": {
                    "keywords": [
                        "Urbem",
                        "Wonderful Business",
                        "Series",
                        "Waters"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "business",
                        "entertainment"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-16",
                "original_text": "Astellas Acquires Xyphos to Boost Immuno-oncology Pipeline",
                "features": {
                    "keywords": [
                        "Astellas",
                        "Acquires",
                        "Xyphos",
                        "Boost",
                        "Immuno-oncology",
                        "Pipeline"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}